Cited 0 time in
Does E-cadherin or N-cadherin or epithelial-mesenchymal transition have a probability of clinical implication of the prognostic marker in invasive ductal carcinoma?
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Lee, J. | - |
| dc.contributor.author | Yang, G. | - |
| dc.contributor.author | Paik, S. S. | - |
| dc.contributor.author | Chung, M. S. | - |
| dc.date.accessioned | 2022-04-01T09:53:59Z | - |
| dc.date.available | 2022-04-01T09:53:59Z | - |
| dc.date.created | 2021-12-31 | - |
| dc.date.issued | 2012-12-15 | - |
| dc.identifier.issn | 0008-5472 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/136414 | - |
| dc.language | 영어 | - |
| dc.language.iso | en | - |
| dc.publisher | AMER ASSOC CANCER RESEARCH | - |
| dc.title | Does E-cadherin or N-cadherin or epithelial-mesenchymal transition have a probability of clinical implication of the prognostic marker in invasive ductal carcinoma? | - |
| dc.type | Conference | - |
| dc.contributor.affiliatedAuthor | Paik, S. S. | - |
| dc.identifier.wosid | 000209704900133 | - |
| dc.identifier.bibliographicCitation | Thirty-Fifth Annual CTRC‐AACR San Antonio Breast Cancer Symposium | - |
| dc.relation.isPartOf | Thirty-Fifth Annual CTRC‐AACR San Antonio Breast Cancer Symposium | - |
| dc.relation.isPartOf | CANCER RESEARCH | - |
| dc.citation.title | Thirty-Fifth Annual CTRC‐AACR San Antonio Breast Cancer Symposium | - |
| dc.citation.conferencePlace | US | - |
| dc.citation.conferencePlace | San Antonio | - |
| dc.citation.conferenceDate | 2012-12-04 | - |
| dc.type.rims | CONF | - |
| dc.description.journalClass | 1 | - |
| dc.identifier.url | https://cancerres.aacrjournals.org/content/72/24_Supplement/P2-10-39 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
